Request an invite

Wainua: how long were the pivotal tox studies?

eplontersen · TTR (ASO)
Longest pivotal study
39 weeks
“In a 39-week study in cynomolgus monkeys, eplontersen (0, 5, 10, or 25 mg/kg SC Q4W) resulted in an increase in complement Bb in HDM, basophilic granules in liver Kupffer cells and kidney tubular cells at the HD, and granular macrophages in the lymph nodes at all doses.”
✓ VerifiedFDA integrated review, p. 129Source ↗
Pivotal GLP studies
GLP SC studies: mouse 13 and 26 weeks; cynomolgus monkey 13 weeks and 9 months (39 weeks)
“The nonclinical studies of eplontersen submitted to the NDA included general toxicology studies of up to 26 weeks (mouse) and 9 months (monkey) in duration”
✓ VerifiedFDA integrated review, p. 49Source ↗
Route in tox
Subcutaneous (weekly, biweekly, monthly regimens)
“The toxicity of eplontersen was investigated with different s.c. administration regimen (weekly, biweekly, monthly) for up to 26 weeks in mice, 14 weeks in rats and up to 39 weeks in monkeys.”
✓ VerifiedEMA assessment report, p. 29Source ↗

Same question, other oligonucleotides

Amvuttra

vutrisiran · TTR (siRNA)
40 weeks

Dawnzera

donidalorsen · Prekallikrein / KLKB1 (ASO)
39 weeks

Givlaari

givosiran · ALAS1 (siRNA)
39 weeks

Izervay

avacincaptad pegol · C5 (aptamer)
39 weeks

Kynamro

mipomersen · APOB (ASO)
52 weeks

Leqvio

inclisiran · PCSK9 (siRNA)
40 weeks

Macugen

pegaptanib · VEGF-165 (aptamer)
39 weeks

Onpattro

patisiran · TTR (siRNA)
39 weeks

Oxlumo

lumasiran · HAO1 (siRNA)
36 weeks

Qalsody

tofersen · SOD1 (ASO)
39 weeks

Qfitlia

fitusiran · Antithrombin / SERPINC1 (siRNA)
39 weeks

Redemplo

plozasiran · APOC3 (siRNA)
37 weeks

Rivfloza

nedosiran · LDHA (siRNA)
39 weeks

Rytelo

imetelstat · Telomerase (oligo)
39 weeks

Spinraza

nusinersen · SMN2 (ASO)
53 weeks

Tegsedi

inotersen · TTR (ASO)
39 weeks

Viltepso

viltolarsen · DMD exon 53 (PMO)
39 weeks

Waylivra

volanesorsen · APOC3 (ASO)
39 weeks

Summary across all 24 oligonucleotides →